Causes of Hospitalization in Patients With Cardiorenal Syndrome Across the Spectrum of Ejection Fraction.
作者信息
Manla Yosef, Kholoki Obada, Attallah Nizar, Bader Feras
机构信息
Department of Cardiology, Heart, Vascular, and Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Department of Nephrology, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
出版信息
Int J Heart Fail. 2024 Jun 25;6(3):137-139. doi: 10.36628/ijhf.2023.0065. eCollection 2024 Jul.
Abstract
摘要
相似文献
1
Causes of Hospitalization in Patients With Cardiorenal Syndrome Across the Spectrum of Ejection Fraction.射血分数范围内的心肾综合征患者的住院原因
Int J Heart Fail. 2024 Jun 25;6(3):137-139. doi: 10.36628/ijhf.2023.0065. eCollection 2024 Jul.
2
Cardiorenal syndrome caused by heart failure with preserved ejection fraction.射血分数保留的心力衰竭所致的心肾综合征
Int J Nephrol. 2011 Feb 7;2011:634903. doi: 10.4061/2011/634903.
3
Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.替米沙坦可改善射血分数保留型心力肾衰所致的心肌纤维化和舒张功能障碍。
Exp Biol Med (Maywood). 2021 Dec;246(23):2511-2521. doi: 10.1177/15353702211035058. Epub 2021 Aug 3.
4
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction.恩格列净对射血分数范围广泛的心力衰竭患者的影响。
Eur Heart J. 2022 Feb 3;43(5):416-426. doi: 10.1093/eurheartj/ehab798.
5
Roles for SGLT2 Inhibitors in Cardiorenal Disease.钠-葡萄糖协同转运蛋白 2 抑制剂在心脏肾脏疾病中的作用。
Cardiorenal Med. 2022;12(3):81-93. doi: 10.1159/000524906. Epub 2022 Jul 14.
6
Cardiorenal syndrome as predictor of in-hospital mortality in ST-segment elevation myocardial infarction.心肾综合征作为ST段抬高型心肌梗死患者院内死亡的预测指标
Clin Investig Arterioscler. 2018 Jul-Aug;30(4):163-169. doi: 10.1016/j.arteri.2017.12.005. Epub 2018 Mar 26.
7
Galectin-3 as a Biomarker to Predict Cardiorenal Syndrome in Patients with Acute Heart Failure.半乳糖凝集素-3作为预测急性心力衰竭患者心肾综合征的生物标志物
Acta Cardiol Sin. 2023 Nov;39(6):862-870. doi: 10.6515/ACS.202311_39(6).20230903A.
8
Heterogeneity in cardiorenal protection by Sodium glucose cotransporter 2 inhibitors in heart failure across the ejection fraction strata: Systematic review and meta-analysis.射血分数各分层中，钠-葡萄糖协同转运蛋白2抑制剂对心力衰竭患者心肾保护作用的异质性：系统评价与荟萃分析
World J Nephrol. 2023 Dec 25;12(5):182-200. doi: 10.5527/wjn.v12.i5.182.
9
Associations of anemia and renal dysfunction with outcomes among patients hospitalized for acute decompensated heart failure with preserved or reduced ejection fraction.射血分数保留或降低的急性失代偿性心力衰竭住院患者中贫血和肾功能不全与预后的关联。
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1912-21. doi: 10.2215/CJN.04400514. Epub 2014 Sep 2.
10
Incident Hospitalization with Major Cardiovascular Diseases and Subsequent Risk of ESKD: Implications for Cardiorenal Syndrome.主要心血管疾病并发入院治疗与随后发生的 ESKD 风险：对心肾综合征的影响。
J Am Soc Nephrol. 2020 Feb;31(2):405-414. doi: 10.1681/ASN.2019060574. Epub 2020 Jan 9.
本文引用的文献
1
Advanced heart failure therapies in the Eastern Mediterranean Region: current status, challenges, and future directions.中东地中海地区的心力衰竭先进治疗方法：现状、挑战和未来方向。
Curr Probl Cardiol. 2024 Jul;49(7):102564. doi: 10.1016/j.cpcardiol.2024.102564. Epub 2024 Apr 8.
2
Acute Heart Failure Is a Malignant Process: But We Can Induce Remission.急性心力衰竭是一个恶性过程：但我们可以诱导缓解。
J Am Heart Assoc. 2023 Nov 7;12(21):e031745. doi: 10.1161/JAHA.123.031745. Epub 2023 Oct 27.
3
The prevalence of cardiorenal anemia syndrome among patients with heart failure and its association with all-cause hospitalizations: a retrospective single-center study from the Middle East.心力衰竭患者中心肾贫血综合征的患病率及其与全因住院的关联：一项来自中东的回顾性单中心研究。
Front Cardiovasc Med. 2023 Sep 12;10:1244275. doi: 10.3389/fcvm.2023.1244275. eCollection 2023.
4
Noncardiovascular morbidity and mortality across left ventricular ejection fraction categories following hospitalization for heart failure.心力衰竭住院后，根据左心室射血分数的不同，非心血管发病率和死亡率。
Rev Esp Cardiol (Engl Ed). 2024 Mar;77(3):206-214. doi: 10.1016/j.rec.2023.05.005. Epub 2023 Jun 12.
5
The burden of metabolic risk factors in North Africa and the Middle East, 1990-2019: findings from the Global Burden of Disease Study.1990 - 2019年北非和中东地区代谢风险因素负担：全球疾病负担研究的结果
EClinicalMedicine. 2023 Jun 2;60:102022. doi: 10.1016/j.eclinm.2023.102022. eCollection 2023 Jun.
6
The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?射血分数降低的心力衰竭（HFrEF）治疗的四大支柱：是否是时候无论射血分数如何都对心力衰竭进行治疗了？
Eur Heart J Suppl. 2022 Dec 19;24(Suppl L):L10-L19. doi: 10.1093/eurheartjsupp/suac113. eCollection 2022 Dec.
7
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction.恩格列净对射血分数范围广泛的心力衰竭患者的影响。
Eur Heart J. 2022 Feb 3;43(5):416-426. doi: 10.1093/eurheartj/ehab798.
8
Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease.慢性肾脏病成人心力衰竭住院的负担和结局。
J Am Coll Cardiol. 2019 Jun 4;73(21):2691-2700. doi: 10.1016/j.jacc.2019.02.071.
9
Insights into cardiorenal interactions in acute decompensated heart failure.急性失代偿性心力衰竭中心肾相互作用的见解
Curr Opin Cardiol. 2017 Mar;32(2):203-208. doi: 10.1097/HCO.0000000000000378.
Zotero 插件